David Viskochil
Clinical Genetics (M.D.) · Salt Lake City, UTNPI 1760561336
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (44.2%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by Sanofi at 47.1% of the total. Reporting peaked in 2019 at $32,402 and has fallen 93.7% since, to $2,043 in 2025.
Across 55 payments — averaging $1356.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$35K
- AstraZeneca$33K
- Takeda Pharmaceuticals U.S.A., Inc.$4K
- Acadia Pharmaceuticals Inc$2K
Across 93 payments — averaging $16,109 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$283K
- Acadia Pharmaceuticals Inc$263K
- Soleno Therapeutics, Inc.$248K
- Amicus Therapeutics, Inc.$231K
- Springworks Therapeutics, Inc.$150K
- Ultragenyx Pharmaceutical Inc.$123K
- plus $201K from 6 others
What the payments were for
- Consulting fees$29,32039%
- Speaking & faculty fees$11,79816%
- Travel & lodging$32,97044%
- Food & beverage$5371%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 23 | $35,143 |
| AstraZeneca(2 entities) | 30 | $33,206 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $4,275 |
| Acadia Pharmaceuticals Inc | 1 | $2,000 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KOSELUGO$19,739
- ALDURAZYME$17,706
- NO PRODUCT DISCUSSED$14,205
- ACP-101$2,000
How this compares
Too few clinical genetics (m.d.) providers in Utahto place this figure against a meaningful peer group, so we don't.
Other clinical genetics (m.d.) in Salt Lake City
- Lorenzo BottoSalt Lake City$2K
- John CareySalt Lake City$2K
- Vanina TaliercioSalt Lake City$920
- Douglas BallSalt Lake City$579
- Stacey ColeSalt Lake City$143
- Steven BleylSalt Lake City$42
- Julie LanderSalt Lake City$40
- Ellen ArchSt George$160
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.